Imported Disease Annotations - MGITerm | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | methylmalonic aciduria and homocystinuria type cblC | | ISS | Thap11 (Mus musculus) | 13592920 | OMIM:277400 | MouseDO | | |
|
Imported Disease Annotations - MGITerm | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | methylmalonic aciduria and homocystinuria type cblC | | ISS | Thap11 (Mus musculus) | 13592920 | OMIM:277400 | MouseDO | | |
|
|
|
|
|
|
|
|
|
|
|
# | Reference Title | Reference Citation |
1. | GOAs Human GO annotations | GOA_HUMAN data from the GO Consortium |
2. | Data Import for Chemical-Gene Interactions | RGD automated import pipeline for gene-chemical interactions |
PMID:8325628 | PMID:9853615 | PMID:12477932 | PMID:12575992 | PMID:15489334 | PMID:18029348 | PMID:18330356 | PMID:18585351 | PMID:18976975 | PMID:19008924 | PMID:19224332 | PMID:19274049 |
PMID:20301503 | PMID:20360068 | PMID:21400515 | PMID:21873635 | PMID:21988832 | PMID:22371484 | PMID:22673507 | PMID:22898364 | PMID:22990118 | PMID:23306615 | PMID:23539139 | PMID:24637716 |
PMID:24740910 | PMID:25056061 | PMID:25416956 | PMID:25437553 | PMID:26186194 | PMID:26496610 | PMID:26975212 | PMID:27173435 | PMID:27576892 | PMID:28449119 | PMID:28514442 | PMID:29150431 |
PMID:29269392 | PMID:29507755 | PMID:30463901 | PMID:31041561 | PMID:31905202 | PMID:31969497 | PMID:31980649 | PMID:32296183 | PMID:32807901 | PMID:32908912 | PMID:32994395 | PMID:33658012 |
PMID:33961781 | PMID:35140242 | PMID:35156780 | PMID:35241646 | PMID:35439318 | PMID:35748872 | PMID:35906200 | PMID:35944360 | PMID:36244648 | PMID:36543142 | PMID:36688959 | PMID:37148549 |
PMID:38113319 | PMID:38113892 |
THAP11 (Homo sapiens - human) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Thap11 (Mus musculus - house mouse) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Thap11 (Rattus norvegicus - Norway rat) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Thap11 (Chinchilla lanigera - long-tailed chinchilla) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
THAP11 (Pan paniscus - bonobo/pygmy chimpanzee) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
THAP11 (Canis lupus familiaris - dog) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Thap11 (Ictidomys tridecemlineatus - thirteen-lined ground squirrel) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
THAP11 (Sus scrofa - pig) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
THAP11 (Chlorocebus sabaeus - green monkey) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Thap11 (Heterocephalus glaber - naked mole-rat) |
|
.
Variants in THAP11
50 total Variants |
Name | Type | Condition(s) | Position(s) | Clinical significance |
GRCh38/hg38 16q13-22.2(chr16:56883592-71279975)x3 | copy number gain | See cases [RCV000052405] | Chr16:56883592..71279975 [GRCh38] Chr16:56917504..71313878 [GRCh37] Chr16:55475005..69871379 [NCBI36] Chr16:16q13-22.2 |
pathogenic |
GRCh38/hg38 16q21-23.1(chr16:58456122-74708723)x3 | copy number gain | See cases [RCV000052408] | Chr16:58456122..74708723 [GRCh38] Chr16:58490026..74742621 [GRCh37] Chr16:57047527..73300122 [NCBI36] Chr16:16q21-23.1 |
pathogenic |
GRCh38/hg38 16q21-24.3(chr16:65313395-90081985)x3 | copy number gain | See cases [RCV000052421] | Chr16:65313395..90081985 [GRCh38] Chr16:65347298..90148393 [GRCh37] Chr16:63904799..88675894 [NCBI36] Chr16:16q21-24.3 |
pathogenic |
GRCh38/hg38 16q21-22.1(chr16:63318997-70555249)x1 | copy number loss | Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053334]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053334]|See cases [RCV000053334] | Chr16:63318997..70555249 [GRCh38] Chr16:63352901..70589152 [GRCh37] Chr16:61910402..69146653 [NCBI36] Chr16:16q21-22.1 |
pathogenic |
GRCh38/hg38 16q21-22.1(chr16:64311275-68062011)x1 | copy number loss | See cases [RCV000053335] | Chr16:64311275..68062011 [GRCh38] Chr16:64345179..68095914 [GRCh37] Chr16:62902680..66653415 [NCBI36] Chr16:16q21-22.1 |
pathogenic |
GRCh38/hg38 16q22.1(chr16:66694180-67865445)x1 | copy number loss | See cases [RCV000053336] | Chr16:66694180..67865445 [GRCh38] Chr16:66728083..67899348 [GRCh37] Chr16:65285584..66456849 [NCBI36] Chr16:16q22.1 |
pathogenic |
GRCh38/hg38 16q21-24.1(chr16:62925929-84585795)x3 | copy number gain | See cases [RCV000135863] | Chr16:62925929..84585795 [GRCh38] Chr16:62959833..84619401 [GRCh37] Chr16:61517334..83176902 [NCBI36] Chr16:16q21-24.1 |
pathogenic |
GRCh38/hg38 16q21-24.3(chr16:65511483-90096995)x3 | copy number gain | See cases [RCV000139426] | Chr16:65511483..90096995 [GRCh38] Chr16:65545386..90163403 [GRCh37] Chr16:64102887..88690904 [NCBI36] Chr16:16q21-24.3 |
pathogenic |
GRCh38/hg38 16q21-24.3(chr16:64389378-90081985)x3 | copy number gain | See cases [RCV000142578] | Chr16:64389378..90081985 [GRCh38] Chr16:64423281..90148393 [GRCh37] Chr16:62980782..88675894 [NCBI36] Chr16:16q21-24.3 |
pathogenic|likely pathogenic |
GRCh38/hg38 16q12.2-24.3(chr16:52899183-90088654)x3 | copy number gain | See cases [RCV000143425] | Chr16:52899183..90088654 [GRCh38] Chr16:52933095..90155062 [GRCh37] Chr16:51490596..88682563 [NCBI36] Chr16:16q12.2-24.3 |
pathogenic |
GRCh38/hg38 16q12.1-22.1(chr16:49685521-68401712)x3 | copy number gain | See cases [RCV000143752] | Chr16:49685521..68401712 [GRCh38] Chr16:49719432..68435615 [GRCh37] Chr16:48276933..66993116 [NCBI36] Chr16:16q12.1-22.1 |
pathogenic |
GRCh38/hg38 16q21-23.3(chr16:65957829-83611443)x3 | copy number gain | See cases [RCV000143742] | Chr16:65957829..83611443 [GRCh38] Chr16:65991732..83645048 [GRCh37] Chr16:64549233..82202549 [NCBI36] Chr16:16q21-23.3 |
pathogenic |
GRCh37/hg19 16q11.2-24.3(chr16:46615804-90142285)x1 | copy number loss | Breast ductal adenocarcinoma [RCV000207138] | Chr16:46615804..90142285 [GRCh37] Chr16:16q11.2-24.3 |
uncertain significance |
GRCh37/hg19 16q12.2-22.2(chr16:55359026-70884455)x1 | copy number loss | Breast ductal adenocarcinoma [RCV000207067] | Chr16:55359026..70884455 [GRCh37] Chr16:16q12.2-22.2 |
likely pathogenic|uncertain significance |
Single allele | complex | Breast ductal adenocarcinoma [RCV000207314] | Chr16:56368689..90141355 [GRCh37] Chr16:16q12.2-24.3 |
uncertain significance |
GRCh37/hg19 16q22.1(chr16:67654566-68404073)x1 | copy number loss | See cases [RCV000449234] | Chr16:67654566..68404073 [GRCh37] Chr16:16q22.1 |
likely pathogenic |
GRCh37/hg19 16q11.2-24.3(chr16:46464488-90155062)x3 | copy number gain | See cases [RCV000446110] | Chr16:46464488..90155062 [GRCh37] Chr16:16q11.2-24.3 |
pathogenic |
GRCh37/hg19 16p13.3-q24.3(chr16:69193-90274381)x3 | copy number gain | See cases [RCV000446684] | Chr16:69193..90274381 [GRCh37] Chr16:16p13.3-q24.3 |
pathogenic |
NM_020457.3(THAP11):c.240C>G (p.Phe80Leu) | single nucleotide variant | Disorders of Intracellular Cobalamin Metabolism [RCV002522728]|Methylmalonic acidemia with homocystinuria, type cblX [RCV000498990] | Chr16:67842794 [GRCh38] Chr16:67876697 [GRCh37] Chr16:16q22.1 |
likely pathogenic|not provided |
GRCh37/hg19 16p13.2-q24.3(chr16:9273328-89548493)x3 | copy number gain | See cases [RCV000511622] | Chr16:9273328..89548493 [GRCh37] Chr16:16p13.2-q24.3 |
uncertain significance |
GRCh37/hg19 16q11.2-24.3(chr16:46497599-90354753)x1 | copy number loss | Poly (ADP-Ribose) polymerase inhibitor response [RCV000626429] | Chr16:46497599..90354753 [GRCh37] Chr16:16q11.2-24.3 |
drug response |
GRCh37/hg19 16p13.3-q24.3(chr16:85881-90155062) | copy number gain | See cases [RCV000511296] | Chr16:85881..90155062 [GRCh37] Chr16:16p13.3-q24.3 |
pathogenic |
GRCh37/hg19 16q11.2-24.3(chr16:46455960-90354753)x1 | copy number loss | Poly (ADP-Ribose) polymerase inhibitor response [RCV000626435] | Chr16:46455960..90354753 [GRCh37] Chr16:16q11.2-24.3 |
drug response |
GRCh37/hg19 16q13-24.3(chr16:57051473-89797669)x3 | copy number gain | See cases [RCV000512511] | Chr16:57051473..89797669 [GRCh37] Chr16:16q13-24.3 |
pathogenic |
GRCh37/hg19 16p13.3-q24.3(chr16:85881-90155062)x3 | copy number gain | See cases [RCV000512138] | Chr16:85881..90155062 [GRCh37] Chr16:16p13.3-q24.3 |
pathogenic |
GRCh37/hg19 16q12.2-22.2(chr16:54416050-72453266)x3 | copy number gain | not provided [RCV000683820] | Chr16:54416050..72453266 [GRCh37] Chr16:16q12.2-22.2 |
pathogenic |
GRCh37/hg19 16p13.3-q24.3(chr16:88165-90274695)x3 | copy number gain | not provided [RCV000738918] | Chr16:88165..90274695 [GRCh37] Chr16:16p13.3-q24.3 |
pathogenic |
GRCh37/hg19 16p13.3-q24.3(chr16:61451-90294632)x3 | copy number gain | not provided [RCV000738915] | Chr16:61451..90294632 [GRCh37] Chr16:16p13.3-q24.3 |
pathogenic |
GRCh37/hg19 16p13.3-q24.3(chr16:88165-90163275)x3 | copy number gain | not provided [RCV000738917] | Chr16:88165..90163275 [GRCh37] Chr16:16p13.3-q24.3 |
pathogenic |
GRCh37/hg19 16q22.1(chr16:67132790-68166320) | copy number loss | not provided [RCV000767617] | Chr16:67132790..68166320 [GRCh37] Chr16:16q22.1 |
pathogenic |
NM_020457.3(THAP11):c.-105G>A | single nucleotide variant | not provided [RCV001620720] | Chr16:67842450 [GRCh38] Chr16:67876353 [GRCh37] Chr16:16q22.1 |
benign |
NM_020457.3(THAP11):c.367CAG[9] (p.Gln132del) | microsatellite | THAP11-related condition [RCV003978183]|not provided [RCV000948981] | Chr16:67842921..67842923 [GRCh38] Chr16:67876824..67876826 [GRCh37] Chr16:16q22.1 |
benign |
GRCh37/hg19 16q21-22.1(chr16:65669673-70180183)x1 | copy number loss | not provided [RCV001006797] | Chr16:65669673..70180183 [GRCh37] Chr16:16q21-22.1 |
pathogenic |
NM_025082.4(CENPT):c.-492+5283C>T | single nucleotide variant | not provided [RCV001674276] | Chr16:67842118 [GRCh38] Chr16:67876021 [GRCh37] Chr16:16q22.1 |
benign |
GRCh37/hg19 16q21-24.3(chr16:61524229-90155062)x3 | copy number gain | not provided [RCV001249359] | Chr16:61524229..90155062 [GRCh37] Chr16:16q21-24.3 |
not provided |
GRCh37/hg19 16q22.1(chr16:67765964-68246270)x1 | copy number loss | not provided [RCV001259860] | Chr16:67765964..68246270 [GRCh37] Chr16:16q22.1 |
uncertain significance |
NM_020457.3(THAP11):c.478C>T (p.Leu160Phe) | single nucleotide variant | Inborn genetic diseases [RCV003197148] | Chr16:67843032 [GRCh38] Chr16:67876935 [GRCh37] Chr16:16q22.1 |
uncertain significance |
NM_020457.3(THAP11):c.694G>A (p.Val232Ile) | single nucleotide variant | not provided [RCV001988330] | Chr16:67843248 [GRCh38] Chr16:67877151 [GRCh37] Chr16:16q22.1 |
uncertain significance |
NM_020457.3(THAP11):c.404C>T (p.Pro135Leu) | single nucleotide variant | not provided [RCV001890339] | Chr16:67842958 [GRCh38] Chr16:67876861 [GRCh37] Chr16:16q22.1 |
uncertain significance |
NM_020457.3(THAP11):c.257A>G (p.Asn86Ser) | single nucleotide variant | not provided [RCV001941371] | Chr16:67842811 [GRCh38] Chr16:67876714 [GRCh37] Chr16:16q22.1 |
uncertain significance |
NM_020457.3(THAP11):c.219G>A (p.Thr73=) | single nucleotide variant | not provided [RCV001941985] | Chr16:67842773 [GRCh38] Chr16:67876676 [GRCh37] Chr16:16q22.1 |
likely benign |
NC_000016.9:g.(?_66545871)_(72146396_?)dup | duplication | Dyskeratosis congenita, autosomal dominant 6 [RCV001900384]|Immunodeficiency [RCV001900385]|not provided [RCV001900386] | Chr16:66545871..72146396 [GRCh37] Chr16:16q21-22.2 |
uncertain significance |
NM_020457.3(THAP11):c.366_392del (p.Gln124_Gln132del) | deletion | not provided [RCV002046955] | Chr16:67842903..67842929 [GRCh38] Chr16:67876806..67876832 [GRCh37] Chr16:16q22.1 |
uncertain significance |
NM_020457.3(THAP11):c.523C>G (p.Pro175Ala) | single nucleotide variant | not provided [RCV002010345] | Chr16:67843077 [GRCh38] Chr16:67876980 [GRCh37] Chr16:16q22.1 |
uncertain significance |
NM_020457.3(THAP11):c.321ACAGCAGCAGCAGCAGCAACAGCAGCA[1] (p.Gln124_Gln132del) | microsatellite | not provided [RCV001916743] | Chr16:67842867..67842893 [GRCh38] Chr16:67876770..67876796 [GRCh37] Chr16:16q22.1 |
uncertain significance |
NM_020457.3(THAP11):c.237C>T (p.Ile79=) | single nucleotide variant | not provided [RCV002148742] | Chr16:67842791 [GRCh38] Chr16:67876694 [GRCh37] Chr16:16q22.1 |
likely benign |
NM_020457.3(THAP11):c.366_386del (p.Gln126_Gln132del) | deletion | not provided [RCV002187232] | Chr16:67842903..67842923 [GRCh38] Chr16:67876806..67876826 [GRCh37] Chr16:16q22.1 |
benign |
NM_020457.3(THAP11):c.339_362del (p.Gln125_Gln132del) | deletion | not provided [RCV002129358] | Chr16:67842879..67842902 [GRCh38] Chr16:67876782..67876805 [GRCh37] Chr16:16q22.1 |
likely benign |
NM_020457.3(THAP11):c.366_389del (p.Gln125_Gln132del) | deletion | THAP11-related condition [RCV003933381]|not provided [RCV002111213] | Chr16:67842903..67842926 [GRCh38] Chr16:67876806..67876829 [GRCh37] Chr16:16q22.1 |
benign|likely benign |
NM_020457.3(THAP11):c.367CAG[6] (p.Gln129_Gln132del) | microsatellite | THAP11-related condition [RCV003958635]|not provided [RCV002088517] | Chr16:67842921..67842932 [GRCh38] Chr16:67876824..67876835 [GRCh37] Chr16:16q22.1 |
likely benign |
NM_020457.3(THAP11):c.392_393insACAGCAGCAGCA (p.Gln129_Gln132dup) | microsatellite | not provided [RCV002088826] | Chr16:67842935..67842936 [GRCh38] Chr16:67876838..67876839 [GRCh37] Chr16:16q22.1 |
likely benign |
NM_020457.3(THAP11):c.367CAG[12] (p.Gln131_Gln132dup) | microsatellite | THAP11-related condition [RCV003916318]|not provided [RCV002148549] | Chr16:67842920..67842921 [GRCh38] Chr16:67876823..67876824 [GRCh37] Chr16:16q22.1 |
benign|likely benign |
NM_020457.3(THAP11):c.312GCAGCAGCAACAGCAGCA[3] (p.Gln127_Gln132dup) | microsatellite | not provided [RCV002135329] | Chr16:67842862..67842863 [GRCh38] Chr16:67876765..67876766 [GRCh37] Chr16:16q22.1 |
likely benign |
NM_020457.3(THAP11):c.367CAG[11] (p.Gln132dup) | microsatellite | THAP11-related condition [RCV003923726]|not provided [RCV002106236] | Chr16:67842920..67842921 [GRCh38] Chr16:67876823..67876824 [GRCh37] Chr16:16q22.1 |
benign|likely benign |
NM_020457.3(THAP11):c.135C>T (p.Val45=) | single nucleotide variant | not provided [RCV002076542] | Chr16:67842689 [GRCh38] Chr16:67876592 [GRCh37] Chr16:16q22.1 |
likely benign |
NM_020457.3(THAP11):c.392_393insACAGCAGCAGCAGCAGCAGCA (p.Gln126_Gln132dup) | microsatellite | not provided [RCV002113000] | Chr16:67842926..67842927 [GRCh38] Chr16:67876829..67876830 [GRCh37] Chr16:16q22.1 |
likely benign |
NM_020457.3(THAP11):c.367CAG[8] (p.Gln131_Gln132del) | microsatellite | not provided [RCV002077562] | Chr16:67842921..67842926 [GRCh38] Chr16:67876824..67876829 [GRCh37] Chr16:16q22.1 |
likely benign |
NM_020457.3(THAP11):c.477C>T (p.Thr159=) | single nucleotide variant | not provided [RCV002115830] | Chr16:67843031 [GRCh38] Chr16:67876934 [GRCh37] Chr16:16q22.1 |
benign |
NM_020457.3(THAP11):c.369G>A (p.Gln123=) | single nucleotide variant | not provided [RCV002152240] | Chr16:67842923 [GRCh38] Chr16:67876826 [GRCh37] Chr16:16q22.1 |
likely benign |
NM_020457.3(THAP11):c.367CAG[4] (p.Gln127_Gln132del) | microsatellite | not provided [RCV002147941] | Chr16:67842921..67842938 [GRCh38] Chr16:67876824..67876841 [GRCh37] Chr16:16q22.1 |
likely benign |
NM_020457.3(THAP11):c.366_371dup (p.Gln131_Gln132dup) | duplication | not provided [RCV002209898] | Chr16:67842914..67842915 [GRCh38] Chr16:67876817..67876818 [GRCh37] Chr16:16q22.1 |
likely benign |
NM_020457.3(THAP11):c.348A>G (p.Gln116=) | single nucleotide variant | THAP11-related condition [RCV003916329]|not provided [RCV002151912] | Chr16:67842902 [GRCh38] Chr16:67876805 [GRCh37] Chr16:16q22.1 |
benign |
NM_020457.3(THAP11):c.9C>G (p.Gly3=) | single nucleotide variant | THAP11-related condition [RCV003923734]|not provided [RCV002114286] | Chr16:67842563 [GRCh38] Chr16:67876466 [GRCh37] Chr16:16q22.1 |
benign |
NM_020457.3(THAP11):c.339ACAGCAGCA[1] (p.Gln130_Gln132del) | microsatellite | THAP11-related condition [RCV003923497]|not provided [RCV002197067] | Chr16:67842885..67842893 [GRCh38] Chr16:67876788..67876796 [GRCh37] Chr16:16q22.1 |
benign|likely benign |
NM_020457.3(THAP11):c.321A>G (p.Gln107=) | single nucleotide variant | THAP11-related condition [RCV003913795]|not provided [RCV002108971] | Chr16:67842875 [GRCh38] Chr16:67876778 [GRCh37] Chr16:16q22.1 |
benign |
NM_020457.3(THAP11):c.573A>G (p.Thr191=) | single nucleotide variant | not provided [RCV002121462] | Chr16:67843127 [GRCh38] Chr16:67877030 [GRCh37] Chr16:16q22.1 |
likely benign |
NM_020457.3(THAP11):c.392_393insACAGCAGCAGCAGCAGCAGCAGCA (p.Gln125_Gln132dup) | microsatellite | not provided [RCV002120814] | Chr16:67842923..67842924 [GRCh38] Chr16:67876826..67876827 [GRCh37] Chr16:16q22.1 |
likely benign |
NM_020457.3(THAP11):c.367CAG[7] (p.Gln130_Gln132del) | microsatellite | not provided [RCV002103288] | Chr16:67842921..67842929 [GRCh38] Chr16:67876824..67876832 [GRCh37] Chr16:16q22.1 |
likely benign |
NM_020457.3(THAP11):c.441G>A (p.Pro147=) | single nucleotide variant | not provided [RCV002160143] | Chr16:67842995 [GRCh38] Chr16:67876898 [GRCh37] Chr16:16q22.1 |
likely benign |
NM_020457.3(THAP11):c.366A>G (p.Gln122=) | single nucleotide variant | not provided [RCV002161035] | Chr16:67842920 [GRCh38] Chr16:67876823 [GRCh37] Chr16:16q22.1 |
likely benign |
NM_020457.3(THAP11):c.366_392dup (p.Gln124_Gln132dup) | duplication | THAP11-related condition [RCV003923631]|not provided [RCV002122946] | Chr16:67842902..67842903 [GRCh38] Chr16:67876805..67876806 [GRCh37] Chr16:16q22.1 |
benign|likely benign |
NM_020457.3(THAP11):c.426T>C (p.Thr142=) | single nucleotide variant | not provided [RCV002163165] | Chr16:67842980 [GRCh38] Chr16:67876883 [GRCh37] Chr16:16q22.1 |
likely benign |
GRCh37/hg19 16q11.2-24.3(chr16:46503968-90155062)x3 | copy number gain | not provided [RCV002221458] | Chr16:46503968..90155062 [GRCh37] Chr16:16q11.2-24.3 |
pathogenic |
NM_020457.3(THAP11):c.367CAG[13] (p.Gln130_Gln132dup) | microsatellite | not provided [RCV002083958] | Chr16:67842920..67842921 [GRCh38] Chr16:67876823..67876824 [GRCh37] Chr16:16q22.1 |
likely benign |
NM_020457.3(THAP11):c.18C>T (p.Cys6=) | single nucleotide variant | THAP11-related condition [RCV003911215]|not provided [RCV002182456] | Chr16:67842572 [GRCh38] Chr16:67876475 [GRCh37] Chr16:16q22.1 |
benign|likely benign |
NC_000016.9:g.(?_65821800)_(72146396_?)del | deletion | Dyskeratosis congenita, autosomal dominant 6 [RCV003122496] | Chr16:65821800..72146396 [GRCh37] Chr16:16q21-22.2 |
uncertain significance |
NM_020457.3(THAP11):c.509C>A (p.Pro170Gln) | single nucleotide variant | not provided [RCV002261531] | Chr16:67843063 [GRCh38] Chr16:67876966 [GRCh37] Chr16:16q22.1 |
uncertain significance |
NM_020457.3(THAP11):c.120G>A (p.Val40=) | single nucleotide variant | not provided [RCV002967762] | Chr16:67842674 [GRCh38] Chr16:67876577 [GRCh37] Chr16:16q22.1 |
likely benign |
NM_020457.3(THAP11):c.351GCA[3] (p.Gln131_Gln132del) | microsatellite | not provided [RCV002994329] | Chr16:67842903..67842908 [GRCh38] Chr16:67876806..67876811 [GRCh37] Chr16:16q22.1 |
likely benign |
NM_020457.3(THAP11):c.360G>A (p.Gln120=) | single nucleotide variant | not provided [RCV002904026] | Chr16:67842914 [GRCh38] Chr16:67876817 [GRCh37] Chr16:16q22.1 |
likely benign |
NM_020457.3(THAP11):c.298G>T (p.Ala100Ser) | single nucleotide variant | Inborn genetic diseases [RCV002979968]|not provided [RCV002995981] | Chr16:67842852 [GRCh38] Chr16:67876755 [GRCh37] Chr16:16q22.1 |
uncertain significance |
NM_020457.3(THAP11):c.921C>T (p.Val307=) | single nucleotide variant | not provided [RCV002902931] | Chr16:67843475 [GRCh38] Chr16:67877378 [GRCh37] Chr16:16q22.1 |
likely benign |
NM_020457.3(THAP11):c.351GCA[7] (p.Gln132_Ser133insGlnGln) | microsatellite | THAP11-related condition [RCV003916673]|not provided [RCV002975158] | Chr16:67842902..67842903 [GRCh38] Chr16:67876805..67876806 [GRCh37] Chr16:16q22.1 |
likely benign |
NM_020457.3(THAP11):c.620C>G (p.Ala207Gly) | single nucleotide variant | Inborn genetic diseases [RCV002684323] | Chr16:67843174 [GRCh38] Chr16:67877077 [GRCh37] Chr16:16q22.1 |
uncertain significance |
NM_020457.3(THAP11):c.38A>G (p.Asn13Ser) | single nucleotide variant | Inborn genetic diseases [RCV003357982]|not provided [RCV002691008] | Chr16:67842592 [GRCh38] Chr16:67876495 [GRCh37] Chr16:16q22.1 |
uncertain significance |
NM_020457.3(THAP11):c.348ACAGCAGCAGCAGCAGCA[1] (p.Gln127_Gln132del) | microsatellite | THAP11-related condition [RCV003943567]|not provided [RCV002914034] | Chr16:67842894..67842911 [GRCh38] Chr16:67876797..67876814 [GRCh37] Chr16:16q22.1 |
likely benign |
NM_020457.3(THAP11):c.339_359dup (p.Gln132_Ser133insGlnGlnGlnGlnGlnGlnGln) | duplication | not provided [RCV002572005] | Chr16:67842881..67842882 [GRCh38] Chr16:67876784..67876785 [GRCh37] Chr16:16q22.1 |
likely benign |
NM_020457.3(THAP11):c.348A>C (p.Gln116His) | single nucleotide variant | not provided [RCV002593148] | Chr16:67842902 [GRCh38] Chr16:67876805 [GRCh37] Chr16:16q22.1 |
uncertain significance |
NM_020457.3(THAP11):c.367CAG[19] (p.Gln132_Ser133insGlnGlnGlnGlnGlnGlnGlnGlnGln) | microsatellite | not provided [RCV002999306] | Chr16:67842920..67842921 [GRCh38] Chr16:67876823..67876824 [GRCh37] Chr16:16q22.1 |
likely benign |
NM_020457.3(THAP11):c.366_395del (p.Gln123_Gln132del) | deletion | not provided [RCV003079504] | Chr16:67842903..67842932 [GRCh38] Chr16:67876806..67876835 [GRCh37] Chr16:16q22.1 |
uncertain significance |
NM_020457.3(THAP11):c.394_395delinsTC (p.Gln132Ser) | indel | not provided [RCV003080710] | Chr16:67842948..67842949 [GRCh38] Chr16:67876851..67876852 [GRCh37] Chr16:16q22.1 |
uncertain significance |
NM_020457.3(THAP11):c.240C>T (p.Phe80=) | single nucleotide variant | not provided [RCV002913909] | Chr16:67842794 [GRCh38] Chr16:67876697 [GRCh37] Chr16:16q22.1 |
benign |
NM_020457.3(THAP11):c.348_350del (p.Gln132del) | deletion | not provided [RCV002926759] | Chr16:67842900..67842902 [GRCh38] Chr16:67876803..67876805 [GRCh37] Chr16:16q22.1 |
likely benign |
NM_020457.3(THAP11):c.324GCA[1] (p.Gln129_Gln132del) | microsatellite | not provided [RCV002699983] | Chr16:67842876..67842887 [GRCh38] Chr16:67876779..67876790 [GRCh37] Chr16:16q22.1 |
likely benign |
NM_020457.3(THAP11):c.367CAG[18] (p.Gln132_Ser133insGlnGlnGlnGlnGlnGlnGlnGln) | microsatellite | not provided [RCV002766190] | Chr16:67842920..67842921 [GRCh38] Chr16:67876823..67876824 [GRCh37] Chr16:16q22.1 |
uncertain significance |
NM_020457.3(THAP11):c.357G>A (p.Gln119=) | single nucleotide variant | not provided [RCV002957935] | Chr16:67842911 [GRCh38] Chr16:67876814 [GRCh37] Chr16:16q22.1 |
likely benign |
NM_020457.3(THAP11):c.333_334insAAGCAACAG (p.Gln111_Gln112insLysGlnGln) | insertion | not provided [RCV002595462] | Chr16:67842884..67842885 [GRCh38] Chr16:67876787..67876788 [GRCh37] Chr16:16q22.1 |
uncertain significance |
NM_020457.3(THAP11):c.448G>C (p.Val150Leu) | single nucleotide variant | not provided [RCV002597020] | Chr16:67843002 [GRCh38] Chr16:67876905 [GRCh37] Chr16:16q22.1 |
uncertain significance |
NM_020457.3(THAP11):c.321_335dup (p.Gln132_Ser133insGlnGlnGlnGlnGln) | duplication | not provided [RCV003042350] | Chr16:67842862..67842863 [GRCh38] Chr16:67876765..67876766 [GRCh37] Chr16:16q22.1 |
likely benign |
NM_020457.3(THAP11):c.415A>G (p.Thr139Ala) | single nucleotide variant | not provided [RCV002786399] | Chr16:67842969 [GRCh38] Chr16:67876872 [GRCh37] Chr16:16q22.1 |
uncertain significance |
NM_020457.3(THAP11):c.347_348insGCAGCAGCAGCAGCAGCAACAGCAGCAGCAGCAGCAGCAGCAGCAACAGCAGCA (p.Gln132_Ser133insGlnGlnGlnGlnGlnGlnGlnGlnGlnGlnGlnGlnGlnGlnGlnGlnGlnGln) | insertion | not provided [RCV003042977] | Chr16:67842875..67842876 [GRCh38] Chr16:67876778..67876779 [GRCh37] Chr16:16q22.1 |
uncertain significance |
NM_020457.3(THAP11):c.321_329dup (p.Gln132_Ser133insGlnGlnGln) | duplication | not provided [RCV002958648] | Chr16:67842866..67842867 [GRCh38] Chr16:67876769..67876770 [GRCh37] Chr16:16q22.1 |
likely benign |
NM_020457.3(THAP11):c.366_374del (p.Gln130_Gln132del) | deletion | not provided [RCV002596060] | Chr16:67842912..67842920 [GRCh38] Chr16:67876815..67876823 [GRCh37] Chr16:16q22.1 |
likely benign |
NM_020457.3(THAP11):c.395A>C (p.Gln132Pro) | single nucleotide variant | Inborn genetic diseases [RCV002984423] | Chr16:67842949 [GRCh38] Chr16:67876852 [GRCh37] Chr16:16q22.1 |
uncertain significance |
NM_020457.3(THAP11):c.348_377del (p.Gln123_Gln132del) | deletion | not provided [RCV002919027] | Chr16:67842894..67842923 [GRCh38] Chr16:67876797..67876826 [GRCh37] Chr16:16q22.1 |
uncertain significance |
NM_020457.3(THAP11):c.321_329del (p.Gln130_Gln132del) | deletion | not provided [RCV002644187] | Chr16:67842867..67842875 [GRCh38] Chr16:67876770..67876778 [GRCh37] Chr16:16q22.1 |
likely benign |
NM_020457.3(THAP11):c.383_384insACAGCAGCAGCAGCA (p.Gln132_Ser133insGlnGlnGlnGlnGln) | microsatellite | not provided [RCV002957936] | Chr16:67842923..67842924 [GRCh38] Chr16:67876826..67876827 [GRCh37] Chr16:16q22.1 |
likely benign |
NM_020457.3(THAP11):c.502C>G (p.Gln168Glu) | single nucleotide variant | Inborn genetic diseases [RCV002915918]|not provided [RCV003777942] | Chr16:67843056 [GRCh38] Chr16:67876959 [GRCh37] Chr16:16q22.1 |
uncertain significance |
NM_020457.3(THAP11):c.348ACAGCAGCAGCAGCAGCA[3] (p.Gln132_Ser133insGlnGlnGlnGlnGlnGln) | microsatellite | not provided [RCV002938931] | Chr16:67842893..67842894 [GRCh38] Chr16:67876796..67876797 [GRCh37] Chr16:16q22.1 |
likely benign|uncertain significance |
NM_020457.3(THAP11):c.321ACAGCAGCAGCAGCAGCAACAGCAGCA[3] (p.Gln132_Ser133insGlnGlnGlnGlnGlnGlnGlnGlnGln) | microsatellite | not provided [RCV003087049] | Chr16:67842866..67842867 [GRCh38] Chr16:67876769..67876770 [GRCh37] Chr16:16q22.1 |
uncertain significance |
NM_020457.3(THAP11):c.359_360insACA (p.Gln132_Ser133insGln) | insertion | not provided [RCV002959214] | Chr16:67842911..67842912 [GRCh38] Chr16:67876814..67876815 [GRCh37] Chr16:16q22.1 |
likely benign |
NM_020457.3(THAP11):c.398C>T (p.Ser133Phe) | single nucleotide variant | not provided [RCV003046463] | Chr16:67842952 [GRCh38] Chr16:67876855 [GRCh37] Chr16:16q22.1 |
uncertain significance |
NM_020457.3(THAP11):c.321_326dup (p.Gln132_Ser133insGlnGln) | duplication | not provided [RCV003086256] | Chr16:67842869..67842870 [GRCh38] Chr16:67876772..67876773 [GRCh37] Chr16:16q22.1 |
likely benign |
NM_020457.3(THAP11):c.366_380del (p.Gln128_Gln132del) | deletion | not provided [RCV003089566] | Chr16:67842906..67842920 [GRCh38] Chr16:67876809..67876823 [GRCh37] Chr16:16q22.1 |
likely benign |
NM_020457.3(THAP11):c.374_375insACAGCAGCAGCAGCAGCAACAGCA (p.Gln132_Ser133insGlnGlnGlnGlnGlnGlnGlnGln) | insertion | not provided [RCV003088582] | Chr16:67842923..67842924 [GRCh38] Chr16:67876826..67876827 [GRCh37] Chr16:16q22.1 |
likely benign |
NM_020457.3(THAP11):c.347_348insGCAGCAGCAGCAGCAGCAACAGCAGCA (p.Gln132_Ser133insGlnGlnGlnGlnGlnGlnGlnGlnGln) | microsatellite | not provided [RCV003090536] | Chr16:67842875..67842876 [GRCh38] Chr16:67876778..67876779 [GRCh37] Chr16:16q22.1 |
likely benign |
NM_020457.3(THAP11):c.722G>A (p.Gly241Asp) | single nucleotide variant | not provided [RCV002671803] | Chr16:67843276 [GRCh38] Chr16:67877179 [GRCh37] Chr16:16q22.1 |
uncertain significance |
NM_020457.3(THAP11):c.339ACAGCAGCA[3] (p.Gln132_Ser133insGlnGlnGln) | microsatellite | not provided [RCV002647266] | Chr16:67842884..67842885 [GRCh38] Chr16:67876787..67876788 [GRCh37] Chr16:16q22.1 |
uncertain significance |
NM_020457.3(THAP11):c.397T>C (p.Ser133Pro) | single nucleotide variant | not provided [RCV002598544] | Chr16:67842951 [GRCh38] Chr16:67876854 [GRCh37] Chr16:16q22.1 |
uncertain significance |
NM_020457.3(THAP11):c.395_397del (p.Gln132_Ser133delinsPro) | deletion | not provided [RCV002658292] | Chr16:67842949..67842951 [GRCh38] Chr16:67876852..67876854 [GRCh37] Chr16:16q22.1 |
uncertain significance |
NM_020457.3(THAP11):c.356_357insACAGCA (p.Gln132_Ser133insGlnGln) | insertion | not provided [RCV003072184] | Chr16:67842905..67842906 [GRCh38] Chr16:67876808..67876809 [GRCh37] Chr16:16q22.1 |
uncertain significance |
NM_020457.3(THAP11):c.446T>C (p.Leu149Pro) | single nucleotide variant | not provided [RCV003569772] | Chr16:67843000 [GRCh38] Chr16:67876903 [GRCh37] Chr16:16q22.1 |
uncertain significance |
GRCh37/hg19 16q22.1(chr16:67498380-68754276)x3 | copy number gain | not provided [RCV003485117] | Chr16:67498380..68754276 [GRCh37] Chr16:16q22.1 |
uncertain significance |
NM_020457.3(THAP11):c.381G>A (p.Gln127=) | single nucleotide variant | not provided [RCV003426747] | Chr16:67842935 [GRCh38] Chr16:67876838 [GRCh37] Chr16:16q22.1 |
likely benign |
NM_020457.3(THAP11):c.574G>A (p.Val192Met) | single nucleotide variant | not provided [RCV003571946] | Chr16:67843128 [GRCh38] Chr16:67877031 [GRCh37] Chr16:16q22.1 |
uncertain significance |
NM_020457.3(THAP11):c.383_384insACAGCAGCA (p.Gln132_Ser133insGlnGlnGln) | microsatellite | not provided [RCV003715492] | Chr16:67842929..67842930 [GRCh38] Chr16:67876832..67876833 [GRCh37] Chr16:16q22.1 |
uncertain significance |
NM_020457.3(THAP11):c.347_348insGCAGCAGCAACAGCAGCAGCA (p.Gln132_Ser133insGlnGlnGlnGlnGlnGlnGln) | microsatellite | not provided [RCV003546294] | Chr16:67842893..67842894 [GRCh38] Chr16:67876796..67876797 [GRCh37] Chr16:16q22.1 |
likely benign |
NM_020457.3(THAP11):c.351GCA[6] (p.Gln132_Ser133insGln) | microsatellite | not provided [RCV003545735] | Chr16:67842902..67842903 [GRCh38] Chr16:67876805..67876806 [GRCh37] Chr16:16q22.1 |
uncertain significance |
NM_020457.3(THAP11):c.339A>G (p.Gln113=) | single nucleotide variant | not provided [RCV003545895] | Chr16:67842893 [GRCh38] Chr16:67876796 [GRCh37] Chr16:16q22.1 |
likely benign |
NM_020457.3(THAP11):c.309GCA[1] (p.Gln130_Gln132del) | microsatellite | not provided [RCV003550033] | Chr16:67842863..67842871 [GRCh38] Chr16:67876766..67876774 [GRCh37] Chr16:16q22.1 |
likely benign |
NM_020457.3(THAP11):c.690G>C (p.Val230=) | single nucleotide variant | not provided [RCV003725985] | Chr16:67843244 [GRCh38] Chr16:67877147 [GRCh37] Chr16:16q22.1 |
likely benign |
NM_020457.3(THAP11):c.348_353del (p.Gln131_Gln132del) | deletion | not provided [RCV003697610] | Chr16:67842897..67842902 [GRCh38] Chr16:67876800..67876805 [GRCh37] Chr16:16q22.1 |
likely benign |
NM_020457.3(THAP11):c.225C>G (p.Arg75=) | single nucleotide variant | not provided [RCV003726350] | Chr16:67842779 [GRCh38] Chr16:67876682 [GRCh37] Chr16:16q22.1 |
likely benign |
NM_020457.3(THAP11):c.367CAG[5] (p.Gln128_Gln132del) | microsatellite | THAP11-related condition [RCV003946656]|not provided [RCV003548314] | Chr16:67842921..67842935 [GRCh38] Chr16:67876824..67876838 [GRCh37] Chr16:16q22.1 |
likely benign |
NM_020457.3(THAP11):c.375G>A (p.Gln125=) | single nucleotide variant | not provided [RCV003816823] | Chr16:67842929 [GRCh38] Chr16:67876832 [GRCh37] Chr16:16q22.1 |
likely benign |
NM_020457.3(THAP11):c.312GCAGCAGCAACAGCAGCA[1] (p.Gln127_Gln132del) | microsatellite | not provided [RCV003700279] | Chr16:67842863..67842880 [GRCh38] Chr16:67876766..67876783 [GRCh37] Chr16:16q22.1 |
likely benign |
NM_020457.3(THAP11):c.366_368del (p.Gln132del) | deletion | not provided [RCV003700340] | Chr16:67842918..67842920 [GRCh38] Chr16:67876821..67876823 [GRCh37] Chr16:16q22.1 |
likely benign |
NM_020457.3(THAP11):c.392_393insACAGCAGCA (p.Gln132_Ser133insGlnGlnGln) | microsatellite | not provided [RCV003847553] | Chr16:67842938..67842939 [GRCh38] Chr16:67876841..67876842 [GRCh37] Chr16:16q22.1 |
uncertain significance |
NM_020457.3(THAP11):c.364_396del (p.Gln122_Gln132del) | deletion | not provided [RCV003731816] | Chr16:67842903..67842935 [GRCh38] Chr16:67876806..67876838 [GRCh37] Chr16:16q22.1 |
uncertain significance |
NM_020457.3(THAP11):c.386_387insACAGCAGCAGCAGCAGCA (p.Gln132_Ser133insGlnGlnGlnGlnGlnGln) | microsatellite | not provided [RCV003735757] | Chr16:67842923..67842924 [GRCh38] Chr16:67876826..67876827 [GRCh37] Chr16:16q22.1 |
uncertain significance |
NM_020457.3(THAP11):c.588T>C (p.Phe196=) | single nucleotide variant | not provided [RCV003711555] | Chr16:67843142 [GRCh38] Chr16:67877045 [GRCh37] Chr16:16q22.1 |
uncertain significance |
NM_020457.3(THAP11):c.464C>G (p.Ala155Gly) | single nucleotide variant | not provided [RCV003676501] | Chr16:67843018 [GRCh38] Chr16:67876921 [GRCh37] Chr16:16q22.1 |
uncertain significance |
NM_020457.3(THAP11):c.321_323del (p.Gln132del) | deletion | not provided [RCV003554057] | Chr16:67842873..67842875 [GRCh38] Chr16:67876776..67876778 [GRCh37] Chr16:16q22.1 |
likely benign |
NM_020457.3(THAP11):c.81A>C (p.Pro27=) | single nucleotide variant | not provided [RCV003732985] | Chr16:67842635 [GRCh38] Chr16:67876538 [GRCh37] Chr16:16q22.1 |
uncertain significance |
NM_020457.3(THAP11):c.351GCA[8] (p.Gln132_Ser133insGlnGlnGln) | microsatellite | not provided [RCV003871121] | Chr16:67842902..67842903 [GRCh38] Chr16:67876805..67876806 [GRCh37] Chr16:16q22.1 |
uncertain significance |
NM_020457.3(THAP11):c.487A>T (p.Thr163Ser) | single nucleotide variant | not provided [RCV003554359] | Chr16:67843041 [GRCh38] Chr16:67876944 [GRCh37] Chr16:16q22.1 |
uncertain significance |
NM_020457.3(THAP11):c.392_393insACAGCAGCAGCAGCAGCA (p.Gln132_Ser133insGlnGlnGlnGlnGlnGln) | microsatellite | not provided [RCV003728765] | Chr16:67842929..67842930 [GRCh38] Chr16:67876832..67876833 [GRCh37] Chr16:16q22.1 |
uncertain significance |
GRCh37/hg19 16q22.1(chr16:67583728-69977397)x3 | copy number gain | not specified [RCV003987175] | Chr16:67583728..69977397 [GRCh37] Chr16:16q22.1 |
uncertain significance |
NM_020457.3(THAP11):c.367CAG[15] (p.Gln132_Ser133insGlnGlnGlnGlnGln) | microsatellite | not provided [RCV003555740] | Chr16:67842920..67842921 [GRCh38] Chr16:67876823..67876824 [GRCh37] Chr16:16q22.1 |
likely benign |
NM_020457.3(THAP11):c.324GCA[6] (p.Gln132_Ser133insGln) | microsatellite | not provided [RCV003564480] | Chr16:67842875..67842876 [GRCh38] Chr16:67876778..67876779 [GRCh37] Chr16:16q22.1 |
uncertain significance |
NM_020457.3(THAP11):c.321_332del (p.Gln129_Gln132del) | deletion | not provided [RCV003567495] | Chr16:67842864..67842875 [GRCh38] Chr16:67876767..67876778 [GRCh37] Chr16:16q22.1 |
likely benign |
NM_020457.3(THAP11):c.374_375insACAGCA (p.Gln132_Ser133insGlnGln) | insertion | not provided [RCV003555048] | Chr16:67842923..67842924 [GRCh38] Chr16:67876826..67876827 [GRCh37] Chr16:16q22.1 |
likely benign |
The detailed report is available here: | Full Report | CSV | TAB | Printer | ||||
miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/). For more information about miRGate, see PMID:25858286 or access the full paper here. |
D16S667E |
|
||||||||||||||||||||||||||||||||||||||||
G20704 |
|
||||||||||||||||||||||||||||||||||||||||
A006C32 |
|
||||||||||||||||||||||||||||||||||||||||
RH78543 |
|
alimentary part of gastrointestinal system | circulatory system | endocrine system | exocrine system | hemolymphoid system | hepatobiliary system | integumental system | musculoskeletal system | nervous system | renal system | reproductive system | respiratory system | sensory system | visual system | adipose tissue | appendage | entire extraembryonic component | pharyngeal arch | |
High | ||||||||||||||||||
Medium | 2421 | 2610 | 1524 | 441 | 1742 | 283 | 4352 | 2065 | 3298 | 381 | 1455 | 1602 | 172 | 1 | 1201 | 2787 | 6 | 2 |
Low | 18 | 381 | 202 | 183 | 209 | 182 | 5 | 132 | 436 | 38 | 5 | 11 | 2 | 3 | 1 | |||
Below cutoff |
RefSeq Transcripts | NM_020457 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles |
GenBank Nucleotide | AB015338 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles |
AC040162 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AK289367 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
BC012182 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
BI261822 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
BQ898449 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
CH471092 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
CP068262 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
EF036502 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
EU869208 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
KT584493 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
L10378 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
L10379 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles |
RefSeq Acc Id: | ENST00000303596 ⟹ ENSP00000304689 | ||||||||
Type: | CODING | ||||||||
Position: |
|
RefSeq Acc Id: | NM_020457 ⟹ NP_065190 | ||||||||||||||||||||||||||||||||
RefSeq Status: | REVIEWED | ||||||||||||||||||||||||||||||||
Type: | CODING | ||||||||||||||||||||||||||||||||
Position: |
|
||||||||||||||||||||||||||||||||
Sequence: |
Protein RefSeqs | NP_065190 | (Get FASTA) | NCBI Sequence Viewer |
GenBank Protein | AAH12182 | (Get FASTA) | NCBI Sequence Viewer |
ABO65088 | (Get FASTA) | NCBI Sequence Viewer | |
ACG50140 | (Get FASTA) | NCBI Sequence Viewer | |
BAA34796 | (Get FASTA) | NCBI Sequence Viewer | |
BAF82056 | (Get FASTA) | NCBI Sequence Viewer | |
EAW83180 | (Get FASTA) | NCBI Sequence Viewer | |
Ensembl Protein | ENSP00000304689 | ||
ENSP00000304689.1 | |||
GenBank Protein | Q96EK4 | (Get FASTA) | NCBI Sequence Viewer |
RefSeq Acc Id: | NP_065190 ⟸ NM_020457 |
- UniProtKB: | A8K002 (UniProtKB/Swiss-Prot), A4UCT5 (UniProtKB/Swiss-Prot), O94795 (UniProtKB/Swiss-Prot), Q96EK4 (UniProtKB/Swiss-Prot) |
- Sequence: |
RefSeq Acc Id: | ENSP00000304689 ⟸ ENST00000303596 |
Name | Modeler | Protein Id | AA Range | Protein Structure |
AF-Q96EK4-F1-model_v2 | AlphaFold | Q96EK4 | 1-314 | view protein structure |
RGD ID: | 6793508 | ||||||||
Promoter ID: | HG_KWN:24055 | ||||||||
Type: | CpG-Island | ||||||||
SO ACC ID: | SO:0000170 | ||||||||
Source: | MPROMDB | ||||||||
Tissues & Cell Lines: | CD4+TCell, CD4+TCell_12Hour, CD4+TCell_2Hour, HeLa_S3, Jurkat, K562, Lymphoblastoid, NB4 | ||||||||
Transcripts: | OTTHUMT00000268879 | ||||||||
Position: |
|
Database | Acc Id | Source(s) |
AGR Gene | HGNC:23194 | AgrOrtholog |
COSMIC | THAP11 | COSMIC |
Ensembl Genes | ENSG00000168286 | Ensembl, ENTREZGENE, UniProtKB/Swiss-Prot |
Ensembl Transcript | ENST00000303596 | ENTREZGENE |
ENST00000303596.3 | UniProtKB/Swiss-Prot | |
GTEx | ENSG00000168286 | GTEx |
HGNC ID | HGNC:23194 | ENTREZGENE |
Human Proteome Map | THAP11 | Human Proteome Map |
InterPro | THAP_Znf | UniProtKB/Swiss-Prot |
KEGG Report | hsa:57215 | UniProtKB/Swiss-Prot |
NCBI Gene | 57215 | ENTREZGENE |
OMIM | 609119 | OMIM |
PANTHER | THAP DOMAIN PROTEIN 11 | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL |
THAP DOMAIN-CONTAINING PROTEIN 11 | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL | |
Pfam | THAP | UniProtKB/Swiss-Prot |
PharmGKB | PA134979842 | PharmGKB |
PROSITE | ZF_THAP | UniProtKB/Swiss-Prot |
SMART | DM3 | UniProtKB/Swiss-Prot |
THAP | UniProtKB/Swiss-Prot | |
Superfamily-SCOP | Glucocorticoid receptor-like (DNA-binding domain) | UniProtKB/Swiss-Prot |
UniProt | A4UCT5 | ENTREZGENE |
A8K002 | ENTREZGENE | |
B5APZ3_HUMAN | UniProtKB/TrEMBL | |
O94795 | ENTREZGENE | |
Q96EK4 | ENTREZGENE, UniProtKB/Swiss-Prot | |
UniProt Secondary | A4UCT5 | UniProtKB/Swiss-Prot |
A8K002 | UniProtKB/Swiss-Prot | |
O94795 | UniProtKB/Swiss-Prot |